dm+d

73454001

Articles

Raising the profile of medicines safety: Changing practice and sharing learning from medication incidents

22 August 2019The Patient Safety Alert: Improving medication error incident and reporting1,2  raised the profile of medicines safety in our Trust (CDDFT). Our evolving programme, focussing on…
Search Articles

Refrigerated Storage

DDAVPFerring Pharmaceuticals

Ferring Pharmaceuticals
DDAVP
4 microgram/ml injection

Contact Ferring (UK) in all cases where a deviation from the recommended storage conditions has occurred. Refer to the current BNF for company contact details.

Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk

13 September 2021
London MI Service

DDAVP intranasal solutionFerring Pharmaceuticals

Ferring Pharmaceuticals
DDAVP intranasal solution
0.01% intranasal solution

Contact Ferring (UK) in all cases where a deviation from the recommended storage conditions has occurred. Refer to the current BNF for company contact details.

Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk

13 September 2021
London MI Service

OctimFerring Pharmaceuticals

Ferring Pharmaceuticals
Octim
15microgram/ml injection

Contact Ferring (UK) in all cases where a deviation from the recommended storage conditions has occurred. Refer to the current BNF for company contact details.

Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk

13 September 2021
London MI Service

Lactation Safety Information

DDAVP

DDAVP
Yes
Very limited published evidence of safety
Negligible amounts in breast milk which are likely to be degraded in infant’s GI tract
11 September 2020